Edward van der Horst - Feb 15, 2023 Form 4 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Chief Scientific Officer
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
SNSE
Transactions as of
Feb 15, 2023
Transactions value $
-$14,288
Form type
4
Date filed
9/11/2023, 05:33 PM
Previous filing
Dec 16, 2022
Next filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNSE Common Stock Tax liability -$14.3K -9.53K -15.26% $1.50 52.9K Feb 15, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.